▶ 調査レポート

世界のメトホルミン塩酸塩API市場予測(~2028年):メトホルミンHCL、メトホルミンDC、その他

• 英文タイトル:Global Metformin Hydrochloride API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のメトホルミン塩酸塩API市場予測(~2028年):メトホルミンHCL、メトホルミンDC、その他 / Global Metformin Hydrochloride API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 / GIR-22F19902資料のイメージです。• レポートコード:GIR-22F19902
• 出版社/出版日:GlobalInfoResearch / 2022年11月
• レポート形態:英文、PDF、100ページ
• 納品方法:Eメール(2~3営業日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
「Global Metformin Hydrochloride API Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
グローバルインフォリサーチ社の最新の調査によると、世界のメトホルミン塩酸塩APIの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

メトホルミン塩酸塩API市場はタイプ(種類)とアプリケーション(用途)によって区分されます。2017年~2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・メトホルミンHCL、メトホルミンDC、その他

アプリケーション別セグメントは次のように区分されます。
・メトホルミン塩酸塩錠、メトホルミン塩酸塩徐放錠、その他

世界のメトホルミン塩酸塩API市場の主要な市場プレーヤーは以下のとおりです。
・Wanbury、USV、Shouguang Fukang Pharmaceutical、Vistin Pharma、CR Double-Crane、Keyuan Pharmaceutical、Farmhispania Group、Harman Finochem、Shijiazhuang Polee Pharmaceutical、Aarti Drugs、Exemed Pharmaceuticals

地域別セグメントは次の地域・国をカバーします。
・北米市場(米国、カナダ、メキシコ)
・ヨーロッパ市場(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋市場(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南米市場(ブラジル、アルゼンチン、コロンビア)
・中東・アフリカ市場(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、メトホルミン塩酸塩API製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なメトホルミン塩酸塩APIメーカーの企業概要、2019年~2022年までのメトホルミン塩酸塩APIの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なメトホルミン塩酸塩APIメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別メトホルミン塩酸塩APIの販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までのメトホルミン塩酸塩APIのタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域でのメトホルミン塩酸塩API市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびメトホルミン塩酸塩APIの産業チェーンを掲載しています。
・第13、14、15章では、メトホルミン塩酸塩APIの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- メトホルミン塩酸塩APIの概要
- タイプ別分析(2017年vs2021年vs2028年):メトホルミンHCL、メトホルミンDC、その他
- アプリケーション別分析(2017年vs2021年vs2028年):メトホルミン塩酸塩錠、メトホルミン塩酸塩徐放錠、その他
- 世界のメトホルミン塩酸塩API市場規模・予測
- 世界のメトホルミン塩酸塩API生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- Wanbury、USV、Shouguang Fukang Pharmaceutical、Vistin Pharma、CR Double-Crane、Keyuan Pharmaceutical、Farmhispania Group、Harman Finochem、Shijiazhuang Polee Pharmaceutical、Aarti Drugs、Exemed Pharmaceuticals
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・タイプ別分析2017年-2028年:メトホルミンHCL、メトホルミンDC、その他
・アプリケーション別分析2017年-2028年:メトホルミン塩酸塩錠、メトホルミン塩酸塩徐放錠、その他
・メトホルミン塩酸塩APIの北米市場分析
- メトホルミン塩酸塩APIの北米市場:タイプ別市場規模2017年-2028年
- メトホルミン塩酸塩APIの北米市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・メトホルミン塩酸塩APIのヨーロッパ市場分析
- :メトホルミン塩酸塩APIのヨーロッパ市場:タイプ別市場規模2017年-2028年
- :メトホルミン塩酸塩APIのヨーロッパ市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・メトホルミン塩酸塩APIのアジア太平洋市場分析
- メトホルミン塩酸塩APIのアジア太平洋市場:タイプ別市場規模2017年-2028年
- メトホルミン塩酸塩APIのアジア太平洋市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・メトホルミン塩酸塩APIの南米市場分析
- メトホルミン塩酸塩APIの南米市場:タイプ別市場規模2017年-2028年
- メトホルミン塩酸塩APIの南米市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・メトホルミン塩酸塩APIの中東・アフリカ市場分析
- メトホルミン塩酸塩APIの中東・アフリカ市場:タイプ別市場規模2017年-2028年
- メトホルミン塩酸塩APIの中東・アフリカ市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Metformin Hydrochloride API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Metformin Hydrochloride API market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Metformin Hydrochloride Tablets accounting for % of the Metformin Hydrochloride API global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Metformin HCL segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Metformin Hydrochloride API include Wanbury, USV, Shouguang Fukang Pharmaceutical, Vistin Pharma, and CR Double-Crane, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Metformin Hydrochloride API market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Metformin HCL
Metformin DC
Others
Market segment by Application can be divided into
Metformin Hydrochloride Tablets
Metformin Hydrochloride Extended-Release Tablets
Others
The key market players for global Metformin Hydrochloride API market are listed below:
Wanbury
USV
Shouguang Fukang Pharmaceutical
Vistin Pharma
CR Double-Crane
Keyuan Pharmaceutical
Farmhispania Group
Harman Finochem
Shijiazhuang Polee Pharmaceutical
Aarti Drugs
Exemed Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Metformin Hydrochloride API product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Metformin Hydrochloride API, with price, sales, revenue and global market share of Metformin Hydrochloride API from 2019 to 2022.
Chapter 3, the Metformin Hydrochloride API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Metformin Hydrochloride API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Metformin Hydrochloride API market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Metformin Hydrochloride API.
Chapter 13, 14, and 15, to describe Metformin Hydrochloride API sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Metformin Hydrochloride API Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Metformin Hydrochloride API Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Metformin HCL
1.2.3 Metformin DC
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Metformin Hydrochloride API Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Metformin Hydrochloride Tablets
1.3.3 Metformin Hydrochloride Extended-Release Tablets
1.3.4 Others
1.4 Global Metformin Hydrochloride API Market Size & Forecast
1.4.1 Global Metformin Hydrochloride API Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Metformin Hydrochloride API Sales in Volume (2017-2028)
1.4.3 Global Metformin Hydrochloride API Price (2017-2028)
1.5 Global Metformin Hydrochloride API Production Capacity Analysis
1.5.1 Global Metformin Hydrochloride API Total Production Capacity (2017-2028)
1.5.2 Global Metformin Hydrochloride API Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Metformin Hydrochloride API Market Drivers
1.6.2 Metformin Hydrochloride API Market Restraints
1.6.3 Metformin Hydrochloride API Trends Analysis
2 Manufacturers Profiles
2.1 Wanbury
2.1.1 Wanbury Details
2.1.2 Wanbury Major Business
2.1.3 Wanbury Metformin Hydrochloride API Product and Services
2.1.4 Wanbury Metformin Hydrochloride API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 USV
2.2.1 USV Details
2.2.2 USV Major Business
2.2.3 USV Metformin Hydrochloride API Product and Services
2.2.4 USV Metformin Hydrochloride API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Shouguang Fukang Pharmaceutical
2.3.1 Shouguang Fukang Pharmaceutical Details
2.3.2 Shouguang Fukang Pharmaceutical Major Business
2.3.3 Shouguang Fukang Pharmaceutical Metformin Hydrochloride API Product and Services
2.3.4 Shouguang Fukang Pharmaceutical Metformin Hydrochloride API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Vistin Pharma
2.4.1 Vistin Pharma Details
2.4.2 Vistin Pharma Major Business
2.4.3 Vistin Pharma Metformin Hydrochloride API Product and Services
2.4.4 Vistin Pharma Metformin Hydrochloride API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 CR Double-Crane
2.5.1 CR Double-Crane Details
2.5.2 CR Double-Crane Major Business
2.5.3 CR Double-Crane Metformin Hydrochloride API Product and Services
2.5.4 CR Double-Crane Metformin Hydrochloride API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Keyuan Pharmaceutical
2.6.1 Keyuan Pharmaceutical Details
2.6.2 Keyuan Pharmaceutical Major Business
2.6.3 Keyuan Pharmaceutical Metformin Hydrochloride API Product and Services
2.6.4 Keyuan Pharmaceutical Metformin Hydrochloride API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Farmhispania Group
2.7.1 Farmhispania Group Details
2.7.2 Farmhispania Group Major Business
2.7.3 Farmhispania Group Metformin Hydrochloride API Product and Services
2.7.4 Farmhispania Group Metformin Hydrochloride API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Harman Finochem
2.8.1 Harman Finochem Details
2.8.2 Harman Finochem Major Business
2.8.3 Harman Finochem Metformin Hydrochloride API Product and Services
2.8.4 Harman Finochem Metformin Hydrochloride API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Shijiazhuang Polee Pharmaceutical
2.9.1 Shijiazhuang Polee Pharmaceutical Details
2.9.2 Shijiazhuang Polee Pharmaceutical Major Business
2.9.3 Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride API Product and Services
2.9.4 Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Aarti Drugs
2.10.1 Aarti Drugs Details
2.10.2 Aarti Drugs Major Business
2.10.3 Aarti Drugs Metformin Hydrochloride API Product and Services
2.10.4 Aarti Drugs Metformin Hydrochloride API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Exemed Pharmaceuticals
2.11.1 Exemed Pharmaceuticals Details
2.11.2 Exemed Pharmaceuticals Major Business
2.11.3 Exemed Pharmaceuticals Metformin Hydrochloride API Product and Services
2.11.4 Exemed Pharmaceuticals Metformin Hydrochloride API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Metformin Hydrochloride API Breakdown Data by Manufacturer
3.1 Global Metformin Hydrochloride API Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Metformin Hydrochloride API Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Metformin Hydrochloride API
3.4 Market Concentration Rate
3.4.1 Top 3 Metformin Hydrochloride API Manufacturer Market Share in 2021
3.4.2 Top 6 Metformin Hydrochloride API Manufacturer Market Share in 2021
3.5 Global Metformin Hydrochloride API Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Metformin Hydrochloride API Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Metformin Hydrochloride API Market Size by Region
4.1.1 Global Metformin Hydrochloride API Sales in Volume by Region (2017-2028)
4.1.2 Global Metformin Hydrochloride API Revenue by Region (2017-2028)
4.2 North America Metformin Hydrochloride API Revenue (2017-2028)
4.3 Europe Metformin Hydrochloride API Revenue (2017-2028)
4.4 Asia-Pacific Metformin Hydrochloride API Revenue (2017-2028)
4.5 South America Metformin Hydrochloride API Revenue (2017-2028)
4.6 Middle East and Africa Metformin Hydrochloride API Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Metformin Hydrochloride API Sales in Volume by Type (2017-2028)
5.2 Global Metformin Hydrochloride API Revenue by Type (2017-2028)
5.3 Global Metformin Hydrochloride API Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Metformin Hydrochloride API Sales in Volume by Application (2017-2028)
6.2 Global Metformin Hydrochloride API Revenue by Application (2017-2028)
6.3 Global Metformin Hydrochloride API Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Metformin Hydrochloride API Sales by Type (2017-2028)
7.2 North America Metformin Hydrochloride API Sales by Application (2017-2028)
7.3 North America Metformin Hydrochloride API Market Size by Country
7.3.1 North America Metformin Hydrochloride API Sales in Volume by Country (2017-2028)
7.3.2 North America Metformin Hydrochloride API Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Metformin Hydrochloride API Sales by Type (2017-2028)
8.2 Europe Metformin Hydrochloride API Sales by Application (2017-2028)
8.3 Europe Metformin Hydrochloride API Market Size by Country
8.3.1 Europe Metformin Hydrochloride API Sales in Volume by Country (2017-2028)
8.3.2 Europe Metformin Hydrochloride API Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Metformin Hydrochloride API Sales by Type (2017-2028)
9.2 Asia-Pacific Metformin Hydrochloride API Sales by Application (2017-2028)
9.3 Asia-Pacific Metformin Hydrochloride API Market Size by Region
9.3.1 Asia-Pacific Metformin Hydrochloride API Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Metformin Hydrochloride API Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Metformin Hydrochloride API Sales by Type (2017-2028)
10.2 South America Metformin Hydrochloride API Sales by Application (2017-2028)
10.3 South America Metformin Hydrochloride API Market Size by Country
10.3.1 South America Metformin Hydrochloride API Sales in Volume by Country (2017-2028)
10.3.2 South America Metformin Hydrochloride API Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Metformin Hydrochloride API Sales by Type (2017-2028)
11.2 Middle East & Africa Metformin Hydrochloride API Sales by Application (2017-2028)
11.3 Middle East & Africa Metformin Hydrochloride API Market Size by Country
11.3.1 Middle East & Africa Metformin Hydrochloride API Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Metformin Hydrochloride API Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Metformin Hydrochloride API and Key Manufacturers
12.2 Manufacturing Costs Percentage of Metformin Hydrochloride API
12.3 Metformin Hydrochloride API Production Process
12.4 Metformin Hydrochloride API Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Metformin Hydrochloride API Typical Distributors
13.3 Metformin Hydrochloride API Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer